Neuland Laboratories elevates Saradhi Bolli to Global Head of CDMO Business Development

Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services

India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant

We will continue to expand our range of purified excipients, offering pharmaceutical companies a dependable partner

Defending Public Health: Strategies to safeguard pharmaceutical quality: Raheel Shah, Business Development Director, BDR Pharmaceuticals

This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards

Bayer appoints Dr. Juergen Eckhardt as new Head of Pharmaceuticals Business Development & Licensing/Open Innovation

Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer

Supriya Lifescience Limited appoints of Dr. Shekhar Bhirud as President – Business Development, Strategy and R&D

BioMed X and Biogen launch global neuroimmunology research challenge

Initiative seeks innovative experimental and computational approaches to uncover neural circuits regulating immune function and identify novel therapeutic targets

Teva closes $700M Emalex acquisition

Bolstering neuroscience push with late-stage Tourette therapy

Saurabh Gambhir elevated to Chief Strategy Officer (Global) at Cipla

Prior to joining Cipla, Gambhir built a strong track record across the pharmaceutical and healthcare sectors.

Brooks Instrument launches ultra-compact advanced mass flow controller for research applications

New AMF Series combines industry-leading 1000:1 turndown capability, predictive diagnostics, and digital connectivity in a footprint no larger than a standard Post-it Note pad

Avio Smart appoints Sandeep Pandya to lead global healthcare expansion

Veteran healthcare executive to drive international growth, strategic partnerships, and global commercialization of the company's molecular diagnostics portfolio